Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

ISOLATION OF AMPLIFIED GENES VIA CDNA SUBTRACTIVE HYBRIDIZATION

  • Read more about ISOLATION OF AMPLIFIED GENES VIA CDNA SUBTRACTIVE HYBRIDIZATION
US Patent 5,827,658
Filed on 1996-08-09

CONFORMATIONALLY CONSTRAINED DIACYLGLYCEROL ANALOGUES

  • Read more about CONFORMATIONALLY CONSTRAINED DIACYLGLYCEROL ANALOGUES
US Application 08/786,660
Filed on 1997-01-21

TUMOR SUPPRESSOR GENE POLYPEPTIDES AND RELATED NUCLEIC ACIDS, HOST CELLS, COMPOSITIONS, AND METHODS OF USE IN INHIBITION OF CELL GROWTH..

  • Read more about TUMOR SUPPRESSOR GENE POLYPEPTIDES AND RELATED NUCLEIC ACIDS, HOST CELLS, COMPOSITIONS, AND METHODS OF USE IN INHIBITION OF CELL GROWTH..
Patent Cooperation Treaty
PCT/US2003/013287
Filed on 2003-05-01

Epoxy-Guaiane Derivatives And Treatment of Cancer

  • Read more about Epoxy-Guaiane Derivatives And Treatment of Cancer
Austria
08869946.7
Filed on 2008-12-30

CHIMERIC PAPILLOMAVIRUS-LIKE PARTICLES

  • Read more about CHIMERIC PAPILLOMAVIRUS-LIKE PARTICLES
US Patent 5,855,891
Filed on 1997-01-09

RECOMBINANT RIBONUCLEASE PROTEINS

  • Read more about RECOMBINANT RIBONUCLEASE PROTEINS
Patent Cooperation Treaty
PCT/US1997/002588
Filed on 1997-02-19

THE DESIGN AND CONSTRUCTION OF NON-INFECTIOUS RETROVIRAL MUTANTS DEFICIENT IN GENOMIC RNA

  • Read more about THE DESIGN AND CONSTRUCTION OF NON-INFECTIOUS RETROVIRAL MUTANTS DEFICIENT IN GENOMIC RNA
US Application 08/774,054
Filed on 1996-12-23

ISOLATION AND CHARACTERIZATION OF A NOVEL PRIMATE T-CELL LYMPHOTROPIC VIRUS AND THE USE OF THIS VIRUS OR COMPONENTS THEREOF IN...

  • Read more about ISOLATION AND CHARACTERIZATION OF A NOVEL PRIMATE T-CELL LYMPHOTROPIC VIRUS AND THE USE OF THIS VIRUS OR COMPONENTS THEREOF IN...
US Application 08/727,471
Filed on 1996-10-22

EXTENSION OF A PROTEIN-PROTEIN INTERACTION SURFACE TO INACTIVATE THE FUNCTION OF A CELLULAR PROTEIN

  • Read more about EXTENSION OF A PROTEIN-PROTEIN INTERACTION SURFACE TO INACTIVATE THE FUNCTION OF A CELLULAR PROTEIN
US Patent 5,942,433
Filed on 1996-07-31

DAMPENING OF AN IMMUNODOMINANT EPITOPE OF AN ANTIGEN FOR USE IN PLANT, ANIMAL AND HUMAN VACCINES AND IMMUNOTHERAPIES

  • Read more about DAMPENING OF AN IMMUNODOMINANT EPITOPE OF AN ANTIGEN FOR USE IN PLANT, ANIMAL AND HUMAN VACCINES AND IMMUNOTHERAPIES
US Patent 5,853,724
Filed on 1996-12-13

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1548
  • Page 1549
  • Page 1550
  • Page 1551
  • Page 1552
  • Page 1553
  • Page 1554
  • Page 1555
  • Page 1556
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health